Home | Structured Search | Drug Resource
Find: within
Gout > Prevention Author: Grace P. Teal, MD; Howard A. Fuchs, MD
Editorial changes - 2009-09-02
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up

Tables
Figures
References
Glossary
What's New
Patient Information
Additional Resources
Tools

Rationale:

  • Allopurinol prevents formation of uric acid from purine breakdown products of nuclear material. If allopurinol is not given, uric acid nephropathy with tubular obstruction may occur. Uricosuric drugs are not indicated in this situation.
  • Rasburicase promotes the conversion of uric acid to the more soluble allantoin.

Evidence:

  • Allopurinol and hydration are still the standard of care for this potential complication. Urate oxidase and experimental drugs under development may be useful alternatives (1).
  • A high phosphorus-to-uric acid ratio may precede hyperuricemic acute renal failure as a complication of chemotherapy, with precipitous decreases in peripheral leukocyte counts (2).
  • A review of pediatric use of rasburicase has led to FDA approval for prevention of tumor lysis syndrome in high-risk patients (i.e., those with non-Hodgkin's lymphomas like Burkitt's lymphoma, acute lymphoblastic leukemia, acute myelogenous leukemia), and its use is standard in these situations (3). Patients who are glucose-6-phosphatase deficient must not be given rasburicase.

Comments:

  • None.

FAQs
Grace P. Teal, MD (deceased) has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Howard A. Fuchs, MD, is a consultant for TAP Pharmaceuticals.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.


The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.